Global Intravenous (IV) Equipment Market Overview, 2026-31

Market Dynamic

Market Drivers • Rising Prevalence of Chronic Diseases: A major driver of the global intravenous equipment market is the growing prevalence of chronic and lifestyle related diseases around the world. Conditions such as diabetes, cardiovascular diseases, cancer, and respiratory disorders are increasing due to factors like sedentary lifestyles, aging populations, and urbanization. These chronic conditions often require long term medical interventions that rely heavily on intravenous therapy for the administration of medications, fluids, nutrition, and blood products. For example, chemotherapy for cancer patients and continuous insulin delivery for diabetics necessitate reliable IV solutions, which drives sustained demand for infusion pumps, catheters, securement devices, and other IV supplies. • Expansion of Healthcare Infrastructure: Another key driver is the increasing investment in healthcare infrastructure and rising healthcare expenditure worldwide. Governments and private entities, particularly in emerging economies, are expanding hospital networks, upgrading medical facilities, and integrating advanced medical technologies to meet growing healthcare demands. This includes significant spending on modern intravenous equipment that enhances patient safety, treatment accuracy, and operational efficiency. In developed markets, advanced healthcare systems are also upgrading existing equipment to incorporate safer, smarter IV technologies such as smart infusion pumps and closed systems. Market Challenges • High Cost and Affordability Issues: A significant challenge for the global intravenous equipment market is the high cost associated with advanced IV technologies and equipment. Modern devices like smart pumps, wireless enabled systems, and advanced monitoring accessories are often priced at a premium, which can be a barrier for healthcare providers in resource limited settings. Hospitals and clinics with constrained budgets, especially in developing regions, may struggle to allocate funds for the latest IV solutions, slowing adoption rates and limiting market penetration. • Regulatory Hurdles: Another challenge faced by market players is stringent regulatory requirements and lengthy approval processes for new IV equipment. Regulatory bodies such as the US FDA and European CE authorities enforce rigorous testing and compliance standards to ensure safety and efficacy of medical devices. While these regulations protect patients, they also lengthen time to market for innovative products and increase development costs for manufacturers. Market Trends • Adoption of Smart IV Technologies: A major trend in the global IV equipment market is the accelerated adoption of smart, connected, and automated technologies. Healthcare providers are increasingly integrating features such as wireless connectivity, dose error reduction systems, remote monitoring, and interoperability with electronic health records into IV devices. These technologies enhance treatment precision, minimize medication errors, and streamline clinical workflows by enabling real time tracking of infusion rates and patient data. Smart IV systems also support better documentation and maintenance scheduling, reducing manual workload and improving overall care quality. • Patient Centric and Home Based Care: Another notable trend is the shift toward patient centric care and home based IV therapy solutions. With healthcare systems emphasizing reduced hospital stays and enhanced patient comfort, there is rising demand for portable and user friendly IV equipment suitable for outpatient and home use. This trend is driven by demographic shifts such as aging populations and the increasing incidence of chronic diseases that require ongoing treatment outside traditional hospital environments. Manufacturers are responding by developing compact, intuitive devices that facilitate easier self administration and improved patient experience.

Key Development

• April 2025: BD launched the HemoSphere Alta platform with AI-driven decision support for critical-care hemodynamics. The platform integrates advanced predictive algorithms to anticipate hypotensive events, providing clinicians with real-time insights to improve patient outcomes and optimize workflow efficiency in intensive care and surgical settings. • April 2025: Teleflex secured FDA 510(k) clearance for the AC3 Range intra-aortic balloon pump. The transport-ready IABP supports critically ill cardiac patients during interfacility transfers, offering reliable counterpulsation therapy with enhanced mobility and flexible power options for ambulance and air transport environments. • April 2025: ICU Medical received FDA 510(k) clearance for its Plum Solo™ single channel IV pump, along with updated versions of its Plum Duo™ dual channel pump and LifeShield™ infusion safety software, officially launching its new IV Performance Platform. • March 2025: Merck’s subcutaneous pembrolizumab met non-inferiority versus IV dosing in a Phase 3 trial. The subcutaneous formulation demonstrated equivalent drug exposure and efficacy compared to intravenous administration, while significantly reducing administration time and improving patient convenience in oncology treatment settings. • December 2023: Baxter advances with the first intravenous (IV) Bag Recycling Pilot for U.S. hospitals. Pilot phase successfully demonstrated proof of concept, with more than six tons of plastic IV bag waste diverted from landfills at Northwestern Memorial Hospital. • October 2023: B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy, launched its new Introcan Safety 2 IV Catheter with Multi-Access Blood Control. IV access is a critical element of infusion therapy, and needlestick injuries continue to be a serious risk faced by clinicians in their daily routines, potentially exposing them to bloodborne pathogens. • April 2023: BD (Becton, Dickinson and Company), a leading global medical technology company, launched a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with optimal IV placement. The system features the BD Cue™ Needle Tracking System, offering a high-quality ultrasound image of the needle trajectory, and is compatible with BD Cue™ Needle Tracking-enabled catheters.